Coronary artery disease risk predicted by insulin resistance, plasma lipids, and hypertension in people without diabetes

American Journal of the Medical Sciences

Volumn 319, Issue 2, 2000, Pages 84-88

  Sheu, Wayne Huey Herng ^a   Jeng, Chii Yuan ^b   Young, Mason S ^b   Lee, Wen Jane ^a   Chen, Ying Tsung ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

CAD; Hypertension; Insulin resistance; Lipids

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; RISK ASSESSMENT;

EID: 0034081236     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9629(15)40693-7     Document Type: Article

References (39)

1. Hillson RM, Hockaday TD, Mann JI, et al. Hyperinsulinemia is associated with development of electrocardiographic abnormalities in diabetics. Diabetes Res 1984;1:143-9.
2. Standl E, Janka HU. High serum insulin concentrations in relation to other cardiovascular risk factors in macrovascular disease of type 2 diabetes. Horm Metab Res 1985;15(Suppl): 46-51.
3. Ronnemaa T, Laakso M, Pyorala K, et al. High fasting plasma insulin as an indicator of coronary heart disease in non-insulin-dependent diabetic patients and nondiabetic subjects. Arterioscler Thromb 1991;11:80-90.
4. Welborn JA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 1979;2: 154-60.
5. McKeigue PM, Ferrie JE, Pierpoint T, et al. Association of early-onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinemia. Circulation 1993;87:152-61.
6. Despres JP, Lamarche B, Mauriege P, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996;334:952-7.
7. Young MH, Jeng C-Y, Sheu WH-H, et al. Insulin resistance, glucose intolerance, hyperinsulinemia and dyslipidemia in patients with angiographically demonstrated coronary artery disease. Am J Cardiol 1993;72:458-60.
8. Bressler P, Bailey SR, Matsuda M, et al. Insulin resistance and coronary artery disease. Diabetologia 1996;39:1345-50.
9. Shinozaki K, Suzuki M, Ikebuchi M, et al. Demonstration of insulin resistance in coronary artery disease documented with angiography. Diabetes Care 1996;19:1-7.
10. Howard G, O'Leary DH, Zaccaro D, et al. Insulin sensitivity and atherosclerosis. Circulation 1996;93:1809-17.
11. Bonora E, Targher G, Tessari R, et al. Intimal-medial thickness of the carotid artery in nondiabetic and NIDDM patients. Diabetes Care 1997;20:627-31.
12. Laakso M, Sarlund H, Salonen R, et al. Asymptomatic atherosclerosis and insulin resistance. Arterioscler Thromb 1991;11:1068-76.
13. Zavaroni I, Dall'Aglio E, Alpi O, et al. Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride. Atherosclerosis 1985;55:259-66.
14. Laws A, Reaven GM. Evidence for an independent relationship between insulin resistance and fasting plasma HDL choleserol, triglyceride and insulin concentrations. J Intern Med 1992;231:25-30.
15. Ferrannini E, Buzzigoli G, Bonadona R, et al. Insulin resistance in essential hypertension. N Engl J Med 1987;317: 350-7.
16. Shen DC, Shieh SM, Fuh MMT, et al. Resistance to insulin-stimulated glucose uptake in patients with hypertension. J Clin Endocrinol Metab 1988;66:580-3.
17. Fuh MMT, Shieh SM, Wu DA, et al. Abnormalities of carbohydrate and lipid metabolism in patients with hypertension. Arch Intern Med 1987;147:1035-8.
18. Fishman WH. Beta-adrenergic receptor blockers: adverse effects and drug interactions. Hypertension 1988;11(Suppl II):21-9.
19. Weinberger MH. Diuretics and their side effects: dilemma in the treatment of hypertension. Hypertension 1988; 11(Suppl II):16-20.
20. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039-57.
21. Sones FMJ, Shirey EK. Cine coronary arteriography. Mod Concepts Cardiovasc Dis 1962;31:735-8.
22. Judkins MP. Selective coronary arteriography. Part I. A percutaneous transfemoral technique. Radiology 1967;89:815-24.
23. Brown G, Albers JJ, Fisher ID, et al. Regression of coronary disease as a result of intensive lipid-lowering therapy in men with high levels of apoprotein B. N Engl J Med 1990; 232:1289-98.
24. Wahlefeld AW. Triglyceride: determination after enzymatic hydrolysis. In: Bergmeryer HU, editor. Methods of enzymatic analysis. New York: Academic Press; 1974. p. 1831-5.
25. Allain CA, Poon LS, Chan SCG, et al. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-5.
26. Bachorik PS, Albers JJ. Precipitation methods of quantification of lipoproteins. Methods Enzymol 1986;129:78-100.
27. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein in plasma without the use of preparative ultracentrifuge. Clin Chem 1972; 18:449-502.
28. Kadish AH, Litle RC, Sternberg JC. A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clin Chem 1968;14:116-31.
29. Hales CN, Randle PJ. Immunoassay of insulin and insulin-antibody precipitate. Biochem J 1963;88:137-46.
30. Sheu WH-H, Shieh S-M, Fuh MM-T, et al. Insulin resistance, glucose intolerance, and hyperinsulinemia. Hyper-triglyceridemia versus hypercholesterolemia. Arterioscler Thromb 1993;13:367-70.
31. Shen S-W, Reaven GM, Farquhar J. Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes. J Clin Invest 1970;49:2151-60.
32. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. JAMA 1993;216:3015-23.
33. Jeng JR, Sheu WHH, Jeng CY, et al. Effect of doxazosin on fibriolysis in hypertensive patients with and without insulin resistance. Am Heart J 1996;132:783-9.
34. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
35. Haffner SM, Stern MP, Hazuda HP, et al. Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 1990;263:2893-8.
36. Ferrannine E, Haffner SM, Michell BD, et al. Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991;3:416-22.
37. Suzuki M, Shinozaki K, Kanazawa A, et al. Insulin resistance as an independent risk factor for carotid wall thickening. Hypertension 1996;28:593-8.
38. Pollare T, Lithell H, Morlin C, et al. Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups. J Hypertens 1989;7:551-9.
39. Harano Y, Kageyama A, Hirose J, et al. Improvement of insulin sensitivity for glucose metabolism with long-acting Ca channel blocker, amlodipine in essential hypertension. Metabolism 1995;44:1-6.